Matches in Nanopublications for { ?s ?p "[This case fits with and extends a recently proposed multistage AML model in which constitutive activation of tyrosine kinases by mutations (BCR-ABL1) are associated with deregulation of transcription factors central to myeloid differentiation (HOXA9 secondary to PICALM-MLLT10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[This case fits with and extends a recently proposed multistage AML model in which constitutive activation of tyrosine kinases by mutations (BCR-ABL1) are associated with deregulation of transcription factors central to myeloid differentiation (HOXA9 secondary to PICALM-MLLT10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP538882.RAC-6z7vSGOltfS3bM4uT-5NSW_LK6O6bCUiAaHD8pdtU130_assertion description "[This case fits with and extends a recently proposed multistage AML model in which constitutive activation of tyrosine kinases by mutations (BCR-ABL1) are associated with deregulation of transcription factors central to myeloid differentiation (HOXA9 secondary to PICALM-MLLT10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538882.RAC-6z7vSGOltfS3bM4uT-5NSW_LK6O6bCUiAaHD8pdtU130_provenance.
- assertion description "[This case fits with and extends a recently proposed multistage AML model in which constitutive activation of tyrosine kinases by mutations (BCR-ABL1) are associated with deregulation of transcription factors central to myeloid differentiation (HOXA9 secondary to PICALM-MLLT10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP788327.RA9K_vrzc3sK3BfzMe2FAOol26iyrSizkASDY0U6zZ8PU130_assertion description "[This case fits with and extends a recently proposed multistage AML model in which constitutive activation of tyrosine kinases by mutations (BCR-ABL1) are associated with deregulation of transcription factors central to myeloid differentiation (HOXA9 secondary to PICALM-MLLT10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788327.RA9K_vrzc3sK3BfzMe2FAOol26iyrSizkASDY0U6zZ8PU130_provenance.
- assertion description "[This case fits with and extends a recently proposed multistage AML model in which constitutive activation of tyrosine kinases by mutations (BCR-ABL1) are associated with deregulation of transcription factors central to myeloid differentiation (HOXA9 secondary to PICALM-MLLT10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP794062.RATvfOY1-eGHUpn5ld5sZ-t8MPAhirEKizrFdIz0hmiPw130_assertion description "[This case fits with and extends a recently proposed multistage AML model in which constitutive activation of tyrosine kinases by mutations (BCR-ABL1) are associated with deregulation of transcription factors central to myeloid differentiation (HOXA9 secondary to PICALM-MLLT10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP794062.RATvfOY1-eGHUpn5ld5sZ-t8MPAhirEKizrFdIz0hmiPw130_provenance.
- NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_assertion description "[This case fits with and extends a recently proposed multistage AML model in which constitutive activation of tyrosine kinases by mutations (BCR-ABL1) are associated with deregulation of transcription factors central to myeloid differentiation (HOXA9 secondary to PICALM-MLLT10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_provenance.
- NP538877.RAcFJm4mqbdgiPzNzPO1iEsNL2xsgN_Cqr0NdoxbgS0VY130_assertion description "[This case fits with and extends a recently proposed multistage AML model in which constitutive activation of tyrosine kinases by mutations (BCR-ABL1) are associated with deregulation of transcription factors central to myeloid differentiation (HOXA9 secondary to PICALM-MLLT10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538877.RAcFJm4mqbdgiPzNzPO1iEsNL2xsgN_Cqr0NdoxbgS0VY130_provenance.
- assertion description "[This case fits with and extends a recently proposed multistage AML model in which constitutive activation of tyrosine kinases by mutations (BCR-ABL1) are associated with deregulation of transcription factors central to myeloid differentiation (HOXA9 secondary to PICALM-MLLT10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This case fits with and extends a recently proposed multistage AML model in which constitutive activation of tyrosine kinases by mutations (BCR-ABL1) are associated with deregulation of transcription factors central to myeloid differentiation (HOXA9 secondary to PICALM-MLLT10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP538879.RAIANmd2m0oDX5PEK4gfeaBxr2jT38gf1uwhqUYi5dW80130_assertion description "[This case fits with and extends a recently proposed multistage AML model in which constitutive activation of tyrosine kinases by mutations (BCR-ABL1) are associated with deregulation of transcription factors central to myeloid differentiation (HOXA9 secondary to PICALM-MLLT10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538879.RAIANmd2m0oDX5PEK4gfeaBxr2jT38gf1uwhqUYi5dW80130_provenance.
- NP538878.RArMW-nZ-aHY0-ZSTiFs6SyWHmNIqasJ58RHeVbfZL7As130_assertion description "[This case fits with and extends a recently proposed multistage AML model in which constitutive activation of tyrosine kinases by mutations (BCR-ABL1) are associated with deregulation of transcription factors central to myeloid differentiation (HOXA9 secondary to PICALM-MLLT10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538878.RArMW-nZ-aHY0-ZSTiFs6SyWHmNIqasJ58RHeVbfZL7As130_provenance.